Patents expiring in 2033

US 8591891

Monoclonal antibodies against ANGPTL4

LEXICON PHARMACEUTICALS, INC. · Granted Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2874019

MELANGE GAZEUX NO/AZOTE A TENEUR ELEVEE EN NO POUR TRAITER LES DETRESSES RESPIRATOIRES HYPOXEMIANTES SEVERES

AIR LIQUIDE SANTE INT [FR] · Granted Thu Nov 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8597946

Enhanced dendritic cells for cancer immunotherapy

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8598170

Dual-acting oxazole antihypertensive agents

Theravance, Inc. · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8598203

Treatment of Crohn's disease with laquinimod

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8598316

Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies

The Regents of the University of California · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8597876

Method of treating HIV infection

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8598364

Oligomer-protease inhibitor conjugates

Nektar Therapeutics · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8598361

Process for preparing 5-fluoro-1H-pyrazolo [3,4-B] pyridin-3-amine and derivatives therof

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8598322

Anti CEACAM1 antibodies and methods of using same

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8598321

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

The Regents of the University of California · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8598333

SiRNA silencing of genes expressed in cancer

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8598312

Inhibitors of antigen presentation by MHC class II molecules

Provid Pharmaceuticals Inc. · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8598313

Compositions for ameliorating cell proliferative disorders and methods of making and using them

The Regents of the University of California · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8598226

Fused cyclic compounds

Takeda Pharmaceutical Company Limited · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8598205

Modulators of cystic fibrosis transmembrane conductance regulator

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8598210

Prolyl hydroxylase inhibitors and methods of use

Akebia Therapeutics, Inc. · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8598174

Pyridazinones, method of making, and method of use thereof

GILEAD CONNECTICUT, INC. · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8598191

Controlled release compositions of gamma-hydroxybutyrate

Supernus Pharmaceuticals, Inc. · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8598181

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8598164

Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8598154

Pyridyl-amine fused azadecalin modulators

Corcept Therapeutics Incorporated · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8598139

Lipid formulated dsRNA targeting the PCSK9 gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8597948

Cloned biological material medical device and method thereof

FIRST PRINCIPLES, INC. · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8598149

Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists

Corcept Therapeutics Incorporated · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8598133

Methods for treating pain

The Regents of the University of Colorado, a Body Corporate · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8598121

Variants of C-type natriuretic peptide

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8597666

Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8597883

Biomarkers for cancer-related fatigue and use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8597898

Fusion polypeptides capable of activating receptors

REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8597660

Therapeutic approach to neurodegenerative disorders using a TFP5-peptide

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8597633

Subcutaneous delivery of poly(oxazoline) conjugates

Serina Therapeutics, Inc. · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8597616

Dry powder drug delivery formulations, methods of use, and devices therefore

The Board of Regents of the University of Texas System · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8597655

Recombinant fusion protein and polynucleotide construct for immunotoxin production

The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8604058

4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

Theravance, Inc. · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8604023

1,4-benzodiazepinone compounds and their use in treating cancer

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8604203

Modulators of cystic fibrosis transmembrane conductance regulator

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8603468

Neutralization of HCV

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8604064

Process for the preparation of roflumilast

TAKEDA GMBH · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8603808

Leishmania vaccine using sand fly salivary immunogen

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8603978

Use of muramyl dipeptide (MDP) for treating inflammation

The United States of America, as represented by the Secretary, Department of Health and Humand Services · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8604244

Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives

REVIVA PHARMACEUTICALS, INC. · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8604033

Preparation of 4-amino-thiazoles and 3-amino-1,2,4-thiadiazoles and their use as allosteric modulators of metabotropic glutamate receptors

Addex Pharma, S.A. · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8603462

Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction

The United States of America—Department of Veterans Affairs · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8604074

Pro-neurogenic compounds

The Board of Regents of the University of Texas System · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8603819

Compositions and methods for generating musculoskeletal tissue

The Regents of the University of California · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8604011

Therapy for treatment of chronic degenerative brain diseases and nervous system injury

The Regents of the University of California · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8603456

Method of treating hair loss with compositions containing interleukin-1

United Technologies UT AG · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)